PharmacyCodes



Tomoxetine [Inn] en es it fr

Tomoxetine [Inn] Brand names, Tomoxetine [Inn] Analogs

Tomoxetine [Inn] Brand Names Mixture

  • No information avaliable

Tomoxetine [Inn] Chemical_Formula

C17H21NO

Tomoxetine [Inn] RX_link

http://www.rxlist.com/cgi/generic3/strattera.htm

Tomoxetine [Inn] fda sheet

Tomoxetine_[Inn] FDA

Tomoxetine [Inn] msds (material safety sheet)

Tomoxetine [Inn] Synthesis Reference

No information avaliable

Tomoxetine [Inn] Molecular Weight

255.355 g/mol

Tomoxetine [Inn] Melting Point

No information avaliable

Tomoxetine [Inn] H2O Solubility

No information avaliable

Tomoxetine [Inn] State

Solid

Tomoxetine [Inn] LogP

4.656

Tomoxetine [Inn] Dosage Forms

Capsule

Tomoxetine [Inn] Indication

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

Tomoxetine [Inn] Pharmacology

Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect.

Tomoxetine [Inn] Absorption

No information avaliable

Tomoxetine [Inn] side effects and Toxicity

No information avaliable

Tomoxetine [Inn] Patient Information

Tomoxetine [Inn] Organisms Affected

Humans and other mammals